Neo Ivy Capital Management initiated a new position in American Healthcare REIT by purchasing 136,925 shares worth approximately $6.44 million. The REIT delivered strong 16.4% same-store NOI growth in Q3, driven by senior housing and integrated senior health campuses segments. Shares have surged 93% over the past year, with management raising full-year guidance.

Dolby Laboratories CEO Kevin J. Yeaman sold 36,699 shares worth approximately $2.5 million on November 24, 2025. Despite the sale, he retains significant direct and indirect ownership. The company reported mixed fiscal year results with modest revenue growth and forecasts continued growth in fiscal 2026.

Dolby Laboratories reported strong Q3 2025 financial results with total revenue of $316 million, up from $289 million in the same quarter last year. The company saw growth across various technology platforms including Dolby Atmos and Dolby Vision in multiple industries.

The global home audio equipment market is projected to grow from $33.2 billion in 2025 to $89.5 billion by 2033, driven by increasing demand for high-quality, immersive audio experiences and innovations in audio technologies.

StarV, a leader in wearable augmented reality (AR) innovation, has launched its Indiegogo campaign for two new AR smart glasses models: StarV Air1 - MYVU and StarV View. These models feature lightweight design, real-time translation, accessibility features, and immersive entertainment capabilities.

Stocks fell ahead of Nvidia's earnings report, with the tech-heavy Nasdaq leading losses. The dollar and gold rose amid heightened risk aversion, while natural gas surged. Bitcoin reached a new record high, defying the risk-off sentiment.

Dolby Laboratories reported strong Q4 2024 earnings, beating expectations, but provided a weaker outlook for fiscal 2025 with declining profits despite mid-single digit sales growth.

Dolby Laboratories (DLB) inks a definitive agreement to acquire GE Licensing from GE Aerospace for $429 million in cash.

Dolby Laboratories (NYSE:DLB) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 1 0 0 0 2M Ago 2 0 0 0 0 3M Ago 0 0 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $98.5, a high estimate of $100.00, and a low estimate of $98.00. Observing a 0.51% increase, the current average has risen from the previous average price target of $98.00. Analyzing Analyst Ratings: A Detailed Breakdown The perception of Dolby Laboratories by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Steven Frankel Rosenblatt Maintains Buy $98.00 $98.00 James Goss Barrington Research Announces Outperform $100.00 - Steve Frankel Rosenblatt Maintains Buy $98.00 $98.00 Steve Frankel Rosenblatt Maintains Buy $98.00 $98.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Dolby Laboratories. ...Full story available on Benzinga.com

Crocs, PlayAGS, Dolby Laboratories, Netflix and Royal Caribbean Cruises are part of the Zacks top Analyst Blog.

LXFR, FCBC, CMRE, MNSO and DLB have been added to the Zacks Rank #1 (Strong Buy) List on May 31, 2023.

Discretionary stocks like Crocs, Inc. (CROX), PlayAGS, Inc. (AGS), Dolby Laboratories, Inc. (DLB), Netflix, Inc. (NFLX) and Royal Caribbean Cruises Ltd. (RCL) are poised to benefit from the rise in consumer confidence in May.